Abstract: Fertilizers that contain urea-aldehyde condensates. The fertilizer can be spherical and can be formed using a granulation and/or spheronization technique and optionally can be an extruded fertilizer that is spheronized.

Abstract: Fertilizer particles with urease inhibitors and nitrification inhibitors are described herein. The fertilizer particles can include a core particle comprising a urease inhibitor and an outer layer comprising a nitrification inhibitor.

Abstract: Urea-aldehyde condensation compositions, processes for preparing the same, and the use of said compositions are disclosed. The compositions can have a nitrogen content that is 100% water soluble and can be used as a fertilizer.

Abstract: Particulate fertilizer compositions that include nitrification inhibitors and urease inhibitors are described herein. The inhibitors are separated from each other by being in separate particles. Fertilizer particles in the composition include particles having a core-shell structure, with an inhibitor included in the core particle.

Abstract: Fertilizer particles with urease inhibitors and nitrification inhibitors are described herein. The fertilizer particles can include a core particle comprising a urease inhibitor and an outer layer comprising a nitrification inhibitor.

Abstract: Particulate fertilizer compositions that include nitrification inhibitors and urease inhibitors are described herein. The inhibitors are separated from each other by being in separate particles. Fertilizer particles in the composition include particles having a core-shell structure, with an inhibitor included in the core particle.

Abstract: Fertilizer particles described herein include a powder composition that can contain one or more urease inhibitors and/or nitrification inhibitors and a filler material embedded within a solid urea matrix. Methods of producing the fertilizer particles involve contacting a powder composition that can contain one or more urease inhibitors and/or nitrification inhibitors and a filler with molten urea under conditions sufficient to form a fertilizer particle having the powder composition embedded within a solid urea matrix.

Abstract: Fertilizer particles with urease inhibitors and nitrification inhibitors are described herein. The fertilizer particles can include a core particle comprising a urease inhibitor and an outer layer comprising a nitrification inhibitor.

Abstract: Fertilizers that contain urea-aldehyde condensates. The fertilizer can be spherical and can be formed using a granulation and/or spheronization technique and optionally can be an extruded fertilizer that is spheronized.

Abstract: Fertilizer particles with urease inhibitors and nitrification inhibitors are described herein. The fertilizer particles can include a core particle comprising a urease inhibitor and an outer layer comprising a nitrification inhibitor.

Abstract: Particulate fertilizer compositions that include nitrification inhibitors and urease inhibitors are described herein. The inhibitors are separated from each other by being in separate particles. Fertilizer particles in the composition include particles having a core-shell structure, with an inhibitor included in the core particle.

Abstract: Urea-aldehyde condensation compositions, processes for preparing the same, and the use of said compositions are disclosed. The compositions can have a nitrogen content that is 100% water soluble and can be used as a fertilizer.

Abstract: Fertilizer particles described herein include a powder composition that can contain one or more urease inhibitors and/or nitrification inhibitors and a filler material embedded within a solid urea matrix. Methods of producing the fertilizer particles involve contacting a powder composition that can contain one or more urease inhibitors and/or nitrification inhibitors and a filler with molten urea under conditions sufficient to form a fertilizer particle having the powder composition embedded within a solid urea matrix.

Abstract: The present invention provides a labelled compound suitable for use as an in vivo imaging agent. The in vivo imaging agent of the invention is useful in the in vivo diagnosis and imaging of fibrosis and in particular fibrosis in the liver. Also provided by the present invention is a method for the preparation of the labelled compound of the invention and a precursor compound useful in said method and a kit useful for carrying out said method. In addition, the present invention provides a pharmaceutical composition comprising the labelled compound of the invention as well as a method of in vivo imaging using the labelled compound of the invention, preferably as the pharmaceutical composition of the invention.

Abstract: The present invention relates to a method of making compounds having affinity for the 1 A subtype of the serotonin receptor, i.e. 5HT1A. The method of the present invention provides advantages over the known methods of synthesis. The compounds obtained by the method of the invention have use in therapeutic methods. The compounds of the invention may also optionally compose a moiety suitable for detection by an in vivo imaging procedure and as such these compounds have use in in vivo imaging methods. The compounds have particular use in the treatment and diagnosis of various neurological and/or psychiatric disorders.

Abstract: The present invention provides a PET tracer that has improved properties for imaging the peripheral benzodiazepine receptor (PBR) as compared with known such PET tracers. The present invention also provides a precursor compound useful in the preparation of the PET tracer of the invention and methods for the preparation of said precursor compound and said PET tracer. Also provided by the present invention is a radiopharmaceutical composition comprising the PET tracer of the invention. Methods for using the PET tracer and the radiopharmaceutical composition are also provided.

Abstract: The present invention relates to sulfonated optical dye compositions, especially dyes suitable for biological applications in vitro, and for in vivo imaging. Improved dye compositions and intermediates are provided, which enable the suppression of undesirable newly-identified impurities. Also provided is the use of the improved dye compositions in the preparation of conjugates with biological targeting molecules.

Abstract: Derivatives of anacardic acid having antimicrobial properties and method for preparing said derivatives. The antimicrobial properties include bacteriostatic and bacteriocidal activity.

Abstract: The present invention provides a PET tracer that has improved properties for imaging the peripheral benzodiazepine receptor (PBR) as compared with known such PET tracers. The present invention also provides a precursor compound useful in the preparation of the PET tracer of the invention and methods for the preparation of said precursor compound and said PET tracer. Also provided by the present invention is a radiopharmaceutical composition comprising the PET tracer of the invention. Methods for using the PET tracer and the radiopharmaceutical composition are also provided.

Abstract: Derivatives of anacardic acid having antimicrobial properties and method for preparing said derivatives. The antimicrobial properties include bacteriostatic and bacteriocidal activity.